The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial

le Coyne, Daniel W
Foilsithe 2012

The future of intravenous iron in nephrology

le Coyne, Daniel W.
Foilsithe in NDT Plus (2011)

Iron Overload in Dialysis Patients: Rust or Bust?

le Coyne, Daniel W.
Foilsithe in Kidney Int Rep (2017)

The Author Replies

le Coyne, Daniel W.
Foilsithe in Kidney Int Rep (2017)

The Author Replies

le Coyne, Daniel W.
Foilsithe in Kidney Int Rep (2017)

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease

le Larson, Derek S., Coyne, Daniel W.
Foilsithe in Kidney Res Clin Pract (2013)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease

le Abbas, Fizza, Coyne, Daniel W.
Foilsithe in Kidney Res Clin Pract (2019)

The Value of Intravenous Iron: Beyond the Cave of Speculation

le Coyne, Daniel W., Fishbane, Steven
Foilsithe in J Am Soc Nephrol (2020)

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD

le Ramakrishnan, Madhuri, Coyne, Daniel W.
Foilsithe in Kidney Med (2020)

Will Targeting Interleukin-6 in the Anemia of CKD Change Our Treatment Paradigm?

le Coyne, Daniel W., Fleming, Robert
Foilsithe in J Am Soc Nephrol (2021)

Changing the paradigms for the treatment of chronic kidney disease

le Coyne, Daniel W., Kovesdy, Csaba P.
Foilsithe in Kidney Int Suppl (2011) (2017)

New options for the anemia of chronic kidney disease

le Coyne, Daniel W., Goldsmith, David, Macdougall, Iain C.
Foilsithe in Kidney Int Suppl (2011) (2017)

Relationship of 1,25 dihydroxy Vitamin D Levels to Clinical Outcomes in Critically Ill Patients with Acute Kidney Injury

le Vijayan, Anitha, Li, Tingting, Dusso, Adriana, Jain, Sanjay, Coyne, Daniel W.
Foilsithe in J Nephrol Ther (2015)

A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD

le Coyne, Daniel W., Goldberg, Seth, Faber, Mark, Ghossein, Cybele, Sprague, Stuart M.
Foilsithe 2014

A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients

le Cheng, Steven C., Young, Daniel O., Huang, Yihung, Delmez, James A., Coyne, Daniel W.
Foilsithe 2008

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

le Coyne, Daniel W., Andress, Dennis L., Amdahl, Michael J., Ritz, Eberhard, de Zeeuw, Dick
Foilsithe 2013

IRON DEFICIENCY ANEMIA AND IRON LOSSES AFTER RENAL TRANSPLANTATION

le Zheng, Sijie, Coyne, Daniel W., Joist, Heidi, Schuessler, Rebecca, Godboldo-Brooks, Ambyr, Ercole, Patrick, Brennan, Daniel C.
Foilsithe 2008

Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease

le Wang, Xuewen, Belani, Sharina, Coyne, Daniel W., Fabbrini, Elisa, Reeds, Dominic N., Patterson, Bruce W., Mittendorfer, Bettina, Klein, Samuel
Foilsithe 2012

Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis

le Charytan, David M., Pai, Amy Barton, Chan, Christopher T., Coyne, Daniel W., Hung, Adriana M., Kovesdy, Csaba P., Fishbane, Steven
Foilsithe in J Am Soc Nephrol (2015)

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

le Kalra, Philip A., Bhandari, Sunil, Saxena, Sanjiv, Agarwal, Dhananjai, Wirtz, Georg, Kletzmayr, Josef, Thomsen, Lars L., Coyne, Daniel W.
Foilsithe in Nephrol Dial Transplant (2016)